Gilead Sciences (Nasdaq: GILD) announced that the company has signed non-exclusive licensing agreements with seven India-based generic pharmaceutical manufacturers to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE